The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk ...

Left atrial appendage closure (LAAC) was well tolerated and may be considered as an alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation refusing oral ...

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

Complex Left Atrial Appendage Occlusion With a Combination of Amplatzer Amulet Left Atrial Appendage Occluder, Amplatzer Vascular Plug and Vascular Coil Receive the the latest news, research, and ...

Left atrial appendage closure was associated with about half as many disabling or fatal strokes and lower mortality after a stroke compared with dual oral anticoagulant therapy in patients with atrial ...

Madrid, Spain – 1 September 2025: No benefit in terms of prevention of ischaemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial ...

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and remains a significant contributor to morbidity and mortality worldwide. A central focus of current research is the left ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Boston Scientific Corporation ...

According to Precedence Research, the global atrial fibrillation devices market size will grow from USD 13.03 billion in 2025 ...